ClinicalTrials.gg
Not yet recruitingNCT07946939Updated Nov 18, 2026

AI-Supported Education in CABG Patients: Effects on Self-Care and Recovery

An interventional study of AI education in Coronary Artery Disease and Coronary Artery Bypass, sponsored by Mersin University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by Mersin University · Not applicable, Interventional, and Supportive care

Updated Nov 18, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
64
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-18

Among 139 studies in Coronary Artery Disease with a site in Turkey — 34 open to participants now, 43 under way, 4 of them phase 3. Coronary Artery Disease · Turkey.

Planned enrollment
42nd of 73
64 · median 70
Started
2026
with 25 others
No phase
60 of 139
18 open now
Primary completion
2026-11
later than 16 of 42 live
Registered
138th of 139
by date

Among the 139 studies in Coronary Artery Disease with a site in Turkey, this one is the 42nd largest by planned enrollment of the 73 interventional ones that give a count, is one of 26 that started in 2026, is one of 60 with no phase, reaches primary completion later than 16 of the 42 other live ones, and was the 138th registered.

Coronary Artery Disease

4,865 studies on the registry are indexed under Coronary Artery Disease; 893 are open to participants now.

Browse Coronary Artery Disease studies →

Open to participants now

34 of the 139 studies in Coronary Artery Disease with a site in Turkey are open now. Recruiting first, the newest first:

29 more — sign in →

All 34 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 589 Coronary Artery Disease studies recruiting now, 403 (68%) set no upper age limit and 68 (12%) stop at 75 or younger; 38 take children under 18; 48 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 139 studies in Coronary Artery Disease with a site in Turkey, or all of them as a file.
02

Study summary

Objective: The objective of this research is to evaluate the effect of artificial intelligence-supported education on post-discharge self-care agency and recovery in patients undergoing coronary artery bypass graft surgery.

Research Hypotheses Three different hypothesis sets have been established for the research. These are:

First Hypothesis Set H0: There is no significant difference in terms of self-care agency between the intervention group receiving artificial intelligence-supported education and the control group receiving routine care.

H1: There is a significant difference in terms of self-care agency between the intervention group receiving artificial intelligence-supported education and the control group receiving routine care.

Second Hypothesis Set H0: There is no significant difference in terms of postoperative recovery between the intervention group receiving artificial intelligence-supported education and the control group receiving routine care.

H1: There is a significant difference in terms of postoperative recovery between the intervention group receiving artificial intelligence-supported education and the control group receiving routine care.

Third Hypothesis Set H0: There is no significant difference in terms of post-discharge hospital readmission rates between the intervention group receiving artificial intelligence-supported education and the control group receiving routine care.

H1: There is a significant difference in terms of post-discharge hospital readmission rates between the intervention group receiving artificial intelligence-supported education and the control group receiving routine care.

Read the detailed description

Coronary artery disease (CAD) is a group of cardiovascular diseases characterized by the reduction or interruption of myocardial blood flow as a result of narrowing or obstruction in the coronary arteries, which supply the oxygen and nutrient requirements of the heart muscle, primarily due to atherosclerotic plaque formation. Responsible for approximately one-third of deaths over the age of thirty-five, CAD is among the leading causes of morbidity and mortality worldwide. In Turkey, 86% of deaths due to diseases are caused by non-communicable diseases, and CAD is responsible for 47% of these deaths. Coronary artery bypass graft (CABG) surgery, which is widely used in the treatment of coronary artery disease, is considered one of the most accepted methods today due to its effectiveness in reducing mortality and morbidity, especially in individuals with advanced CAD. In recent years, the increase in survival rates and lifespan in patients undergoing open-heart surgery has been associated with advancements in cardiopulmonary bypass technologies, progress in surgical techniques, improvement of intensive care practices, and the proliferation of patient-centered multidisciplinary care approaches. The success of CABG surgery is not limited to a successful surgical intervention alone; it requires a comprehensive care process encompassing the preoperative, intraoperative, and postoperative periods. Nurses play a critical role as essential members of the care team during this process. Nurses actively participate in pain management, maintenance of wound care, monitoring of vital signs and hemodynamic parameters, support of early mobilization, and early diagnosis and management of physical and psychosocial complications such as delirium and depression. Furthermore, by providing education, counseling, and psychosocial support services to the patient and their family, they contribute to the development of self-care skills, support the continuity of post-discharge care, and significantly contribute to the improvement of patient outcomes.

It plays a critical role in improving long-term clinical outcomes that patients possess sufficient knowledge and skills in the postoperative period regarding issues such as wound care, adherence to medical treatment, physical activity, dietary habits, smoking cessation, control of CAD risk factors, and early recognition of complication symptoms. It has been reported that in patients who adhere to postoperative care recommendations, complications, hospital readmissions, and cardiovascular events decrease, while quality of life and functional capacity increase. In this context, it has been reported that nurse-led structured education programs, telephone counseling, telehealth (eHealth) applications, video-supported education, and education interventions integrated into rehabilitation programs yield positive results in supporting adherence to treatment and self-care recommendations and the recovery process of patients after CABG. Studies reveal the importance of structured educational requirements in terms of symptom management, self-care practices, and adherence to cardiac rehabilitation in the post-discharge period, and show that educational interventions reduce anxiety and depression levels while supporting physical recovery.

The ability of patients who undergo coronary artery bypass surgery to maintain a successful recovery process in the post-discharge period also depends on their ability to effectively perform self-care behaviors alongside the discharge education provided.

Accordingly, this planned research aims to evaluate the effect of artificial intelligence-supported education on patients' post-discharge self-care agency and recovery process.

03

Conditions studied

  • Coronary Artery Disease
  • Coronary Artery Bypass

Keywords

  • Coronary Artery Bypass Grafting
  • Artificial Intelligence
  • Patient Education
  • Behavior Log
  • Feedback
  • Self-Care Agency
  • Postoperative Recovery
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients who will undergo CABG surgery for the first time
  • Are 18 years of age and older
  • Are conscious, oriented, and cooperative
  • Can read and understand Turkish
  • Do not have any diagnosed psychiatric illness
  • Do not use any psychiatric medication
  • Do not have a hearing impairment
  • Do not have a visual impairment
  • Agree to participate in the study and sign the "Voluntary Form"

Exclusion criteria

Exclusion Criteria:

  • Patients who have previously undergone CABG surgery
  • Have a psychiatric disease diagnosis at a level that would prevent answering questionnaires
  • Have hearing and visual impairments
  • Do not read and understand Turkish
  • Do not want to participate in the study
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
64 participants (estimated)

Study arms

  • Experimental
    AI-supported education group

    The AI-developed educational video will be shown to patients twice: first, within the initial 24 hours following their transfer from the intensive care unit to the ward after surgery, and second, on the day of discharge to reinforce the information provided. The educational video will also be delivered to the patients so they can watch it whenever needed after discharge. During their follow-up visit one week post-discharge, the Postoperative Recovery Index (PoRI), Self-Care Agency Scale, and Patient Evaluation Form will be administered. Measurements will be repeated using the Postoperative Recovery Index (PoRI), Self-Care Agency Scale, and Patient Evaluation Form during their one-month post-discharge follow-up visit.

    Other: AI education

  • No intervention
    Control Group

    Participants in the control group will not receive any intervention other than the standard care and treatment routinely administered in the clinic. Data will be collected by the researcher at the same time points as the intervention group.

Interventions

  • OtherAI education

    The AI-developed educational video will be shown to patients twice: first, within the initial 24 hours following their transfer from the intensive care unit to the ward after surgery, and second, on the day of discharge to reinforce the information provided. The educational video will also be delivered to the patients so they can watch it whenever needed after discharge. During their follow-up visit one week post-discharge, the Postoperative Recovery Index (PoRI), Self-Care Agency Scale, and Patient Evaluation Form will be administered. Measurements will be repeated using the Postoperative Recovery Index (PoRI), Self-Care Agency Scale, and Patient Evaluation Form during their one-month post-discharge follow-up visi

06

What researchers measure

Primary outcomes

  1. "Patient Introductory and Clinical Characteristics Form"

    Prepared by the researcher in accordance with the relevant literature. The form consists of a total of 13 questions examining the sociodemographic and clinical characteristics of the patient.

    Time frame: Within the first 24 hours of admission to the postoperative ward

  2. "Self-Care Agency Scale (SCAS)"

    The scale was developed by Kearney and Fleischer (1979) to determine patients' self-care agency levels. In the scale consisting of a single dimension, each item is scored from 0 to 4 and evaluated based on responses over a 5-point Likert-type scale. A response of 'Does not describe me at all' is given 0 points, 'Does not describe me much' is given 1 point, 'I have no idea' is given 2 points, 'Describes me a little' is given 3 points, and 'Describes me very well' is given 4 points. Items 3, 6, 9, 13, 19, 22, 26, and 31 in the scale are evaluated negatively, and their scoring has been reversed. While the lowest score that can be obtained from the scale is 35, the highest score is 140. An increase in score indicates an increase in self-care agency. The adaptation of the scale to Turkish society was performed by Nahçıvan.

    Time frame: 1st week, 4th week

  3. "Postoperative Recovery Index (PoRI)"

    The Postoperative Recovery Index (PoRI) was developed by Butler and colleagues in 2012 to evaluate patients' postoperative recovery status. The original index consists of 37 items and five sub-dimensions: psychological symptoms, physical activities, general symptoms, bowel symptoms, and urge-desire symptoms. The Turkish validity and reliability study of the index was conducted by Cengiz and Aygin (2019); as a result of the factor analyses performed, the Turkish form was structured to consist of 25 items and five sub-dimensions. The scale is in a 5-point Likert type, and items are evaluated between "never" and "always". In calculating sub-dimension scores, the scores of relevant items are summed and their arithmetic means are taken, while the total index score is obtained by summing the scores of all items and taking the arithmetic mean.

    Time frame: 1st week, 4th week

  4. "Patient Evaluation Form"

    The form, prepared by the researcher in accordance with the relevant literature, was created to monitor the health status of patients undergoing CABG surgery in the post-discharge period. Patients' hospital application requirements and reasons are questioned in the form. The form will be applied at the follow-up times determined within the scope of the research and used to monitor patients' healthcare applications in the post-discharge process.

    Time frame: 1st week, 4th week

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Yes

Supporting information: Study protocol

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Nov 2026, 0 months later.

Of 755 non-industry interventional studies with no phase under Coronary Artery Disease, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 53. This study's planned 0 months is below that.

Counting every sponsor, half of 932 studies reached it within 30 months; a quarter within 15 and three quarters within 50.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 5, 2026
First posted
Nov 18, 2026
StartEst.
Nov 20, 2026
Primary completionEst.
Nov 20, 2026
CompletionEst.
Nov 20, 2027
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07946939
Lead sponsor
Mersin University
Responsible party
Nesrin Temiz (cardıovasculer nurse, Mersin University) — Principal investigator
First posted
Nov 18, 2026
Start date
Nov 20, 2026 (estimated)
Primary completion
Nov 20, 2026 (estimated)
Completion
Nov 20, 2027 (estimated)
Last update
Nov 18, 2026

Study contacts

Nesrin Temiz
Contact
nesrintemiz@mersin.edu.tr
+905435498328

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion